Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
April 26-30, 2011
You are cordially invited to participate in a new meeting on The Biology of Cancer: Microenvironment, Metastasis & Therapeutics to be held at Cold Spring Harbor Laboratory, New York. The meeting will begin on Tuesday, April 26, 2011, and will conclude with lunch on Saturday, April 30. The specific goal of this conference is to bring together a diverse group of scientists studying various aspects of the biology of cancer. The meeting will alternate annually with the CSHL meeting on Mechanisms & Models of Cancer. The format of the meeting will include morning and evening sessions consisting of eight or nine 15-minute talks per session, selected from the abstracts, principally on unpublished work. In addition, there will be two poster sessions, held in the afternoons. The organizers will decide the suitability of each abstract for oral or poster presentation, but please specify if you prefer a poster.
|
|
Invited Speakers:
|
|
Keynote Speaker: Charles Sawyers HHMI/Memorial Sloan Kettering Cancer Center Topics & Speakers Include: Integrated discovery platforms and personalized medicine Alan Ashworth, Breakthrough Breast Cancer Res. Centre, UK David Epstein, OSI Pharmaceuticals Judy Garber, Dana Farber Cancer Institute Cancer cell metabolism Chi Dang, Johns Hopkins University School of Medicine Tak Mak, Ontario Cancer Institute, Canada M. Celeste Simon, University of Pennsylvania Medical School Craig Thompson, University of Pennsylvania Tumor heterogeneity and cancer cell plasticity John Dick, Toronto General Research Institute, Canada Meenhard Herlyn, The Wistar Institute Sean Morrison, University of Michigan Robert Weinberg, Whitehead Institute for Biomedical Research Genetics and biology of tumor cell architecture Patrick Humbert, Peter MacCallum Cancer Institute, Australia Ian Macara, University of Virginia School of Medicine Valerie Weaver, University of California San Francisco Valeri Vasioukhin, Fred Hutchinson Cancer Research Center Modeling cancer in mice: xenograft and genetically engineered models Lynda Chin, Dana Farber Cancer Institute Gerard Evan, University of Cambridge, UK Jos Jonkers, Netherlands Cancer Institute, The Netherlands Scott Lowe, Cold Spring Harbor Laboratory/HHMI Benjamin Neel, Ontario Cancer Institute, Canada Molecular imaging and Targeted drug delivery Kevin Brindle, University of Cambridge, UK Mauro Ferrari, University of Texas, Houston Zena Werb, University of California, San Francisco Tumor immunology Pamela Ohashi, Ontario Research Institute, Canada Douglas Fearon, University of Cambridge, UK James Allison, HHMI/Memorial Sloan Kettering Cancer Center Steven Rosenberg, National Cancer Institute Tumor-stroma interactions–inflammation Mina Bissell, Lawrence Berkeley National Laboratory Lisa Coussens, University of California, San Francisco Michael Karin, University of California, San Diego Joan Massague, Memorial Sloan Kettering Cancer Center
|
|